Vaccine and Treatment Evaluation Unit: Phase I Clinical Trial to Evaluate a Hepatitis E Vaccine

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

Key facts

NIH application ID

10453426

Project number

272201300018I-P00003-27200022-1

Recipient

EMORY UNIVERSITY

Principal Investigator

Mark Joseph Mulligan

Activity code

N01

Funding institute

NIH

Fiscal year

2021

Award amount

$2,714

Award type

—

Project period

2018-04-01 → 2021-09-30